Показано 0 из 0
Дата |
---|
20.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
12.78
|
14.27
|
14.36
|
13.66
|
14.36
|
13.99
|
|
|
65 988.50
|
54.00
|
13.30
|
15.22
|
13.84
|
13.64
|
13.84
|
13.64
|
|
|
823.56
|
6.00
|
13.24
|
16.04
|
14.00
|
13.86
|
14.01
|
13.86
|
|
|
7 816.24
|
13.00
|
13.48
|
16.00
|
14.08
|
13.935
|
14.13
|
13.935
|
|
|
49 196.38
|
46.00
|
13.31
|
16.00
|
14.08
|
13.82
|
14.08
|
13.85
|
|
|
47 369.09
|
27.00
|
|
16.20
|
14.36
|
13.75
|
14.36
|
14.18
|
|
|
23 169.27
|
20.00
|
13.62
|
15.29
|
14.33
|
13.83
|
14.33
|
13.94
|
|
|
26 049.29
|
28.00
|
13.69
|
15.89
|
14.35
|
13.98
|
14.40
|
13.98
|
|
|
43 064.49
|
44.00
|
13.46
|
15.47
|
14.57
|
13.79
|
14.68
|
14.13
|
|
|
116 162.97
|
78.00
|
|
|
15.04
|
14.47
|
15.05
|
14.47
|
|
|
58 616.09
|
61.00
|
Abivax SA, a biotechnology company, develops, markets, and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases in Asia and Latin America.